You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ponatinib

Showing 26 - 50 of 77
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia With

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +5 more
  • Blinatumomab
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2022

Chronic Myeloid Leukemia, Chronic Phase, Adults Trial in Italy (Ponatinib)

Active, not recruiting
  • Chronic Myeloid Leukemia
  • +2 more
  • Ponatinib
  • Alessandria, Italy
  • +36 more
Jan 4, 2022

Iclusig PMS in CML or Ph+ALL Patients

Recruiting
  • Chronic Myeloid Leukemia
  • Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
  • Ponatinib
  • Busan, Korea, Republic of
    Kosin University Gaspel Hospital
Sep 16, 2021

Malignant Hepatobiliary Tumor Trial in Scottsdale (Laboratory Biomarker Analysis, Ponatinib Hydrochloride, Quality-of-Life

Completed
Has Results
  • Malignant Hepatobiliary Neoplasm
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Nov 10, 2020

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 31, 2022

Pediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL), Ph+ Mixed Phenotype Acute Leukemia (MPAL),

Recruiting
  • Pediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL)
  • +2 more
  • Ponatinib
  • +2 more
  • Phoenix, Arizona
  • +69 more
Aug 23, 2022

Chronic Myeloid Leukemia (CML) Trial in Italy (Ponatinib 15mg QD, Ponatinib 30mg QD)

Not yet recruiting
  • Chronic Myeloid Leukemia (CML)
  • Ponatinib 15mg QD
  • Ponatinib 30mg QD
  • Cagliari, Italy
  • +12 more
Jan 31, 2021

Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, ph+ Acute Lymphoblastic Leukemia Trial in Chicago (Inotuzumab ozogamicin,

Recruiting
  • Lymphoblastic Leukemia
  • +2 more
  • Inotuzumab ozogamicin
  • +7 more
  • Chicago, Illinois
    University of Chicago Medical Center
May 16, 2022

Acute Lymphoblastic Leukemia, Adult Trial (Ponatinib, Blinatumomab, Imatinib)

Not yet recruiting
  • Acute Lymphoblastic Leukemia, Adult
  • Ponatinib
  • +2 more
  • (no location specified)
Dec 28, 2020

CML Any Phase of the Disease Treated With Ponatinib (Iclusig®)

Active, not recruiting
  • Chronic Myeloid Leukemia
    • Saint-Pierre, Reunion, France
    • +39 more
    Dec 13, 2021

    Philadelphia Positive, BCR-ABL Positive, Acute Lymphoblastic Leukemia Trial in Italy (Ponatinib)

    Completed
    • Philadelphia Positive
    • +2 more
    • Ponatinib
    • Alessandria, Italy
    • +41 more
    Nov 18, 2021

    Chronic Myeloid Leukemia, Ph+ Acute Lymphoblastic Leukemia Trial in Worldwide (Ponatinib)

    Completed
    Has Results
    • Chronic Myeloid Leukemia
    • Ph+ Acute Lymphoblastic Leukemia
    • Ponatinib
    • St Leonards, New South Wales, Australia
    • +41 more
    Jan 18, 2021

    Myeloid Leukemia, Chronic, Chronic Phase Trial in Worldwide (Ponatinib)

    Active, not recruiting
    Has Results
    • Myeloid Leukemia, Chronic, Chronic Phase
    • Ponatinib
    • Atlanta, Georgia
    • +85 more
    Jan 4, 2022

    Vascular Occlusive Events Associated With ICLUSIG®

    Terminated
    • Myeloid Leukemia, Chronic-Phase, Accelerated-Phase, Blast-Phase, Ph+ALL
      • Hackensack, New Jersey
      • +1 more
      Oct 30, 2020

      CHRONIC MYELOGENOUS LEUKAEMIA IN ACCELERATED PHASE, CHRONIC MYELOGENOUS LEUKAEMIA IN MYELOID BLAST CRISIS Trial in France

      Recruiting
      • CHRONIC MYELOGENOUS LEUKAEMIA IN ACCELERATED PHASE
      • CHRONIC MYELOGENOUS LEUKAEMIA IN MYELOID BLAST CRISIS
      • Amiens, France
      • +28 more
      Aug 6, 2020

      Malignant Tumor Trial in Ann Arbor, Columbus (ponatinib HCl, laboratory biomarker analysis)

      Unknown status
      • Malignant Neoplasm
      • ponatinib hydrochloride
      • laboratory biomarker analysis
      • Ann Arbor, Michigan
      • +1 more
      Feb 14, 2020

      Breast Cancer, Gastrointestinal Cancer, Non Small Cell Lung Cancer Trial in Italy (Erlotinib, Trastuzumab, Trastuzumab

      Recruiting
      • Breast Cancer
      • +3 more
      • Ancona, Italy
      • +40 more
      Jan 25, 2023

      Acute Myeloid Lukemia Trial in France (Ponatinib and Cytarabine)

      Active, not recruiting
      • Acute Myeloid Lukemia
      • Ponatinib and Cytarabine
      • Aix-en-Provence, France
      • +36 more
      Aug 6, 2020

      Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in China (Ponatinib)

      Recruiting
      • Chronic Myeloid Leukemia
      • Acute Lymphoblastic Leukemia
      • Ponatinib
      • Hefei, Anhui, China
      • +13 more
      Aug 11, 2020

      Non Small Cell Lung Cancer Trial in United States (Ponatinib)

      Completed
      Has Results
      • Non Small Cell Lung Cancer
      • Ponatinib
      • Orange, California
      • +4 more
      Dec 8, 2019

      Leukemia Trial in Houston (Ponatinib)

      Terminated
      Has Results
      • Leukemia
      • Ponatinib
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Sep 16, 2019

      Tyrosine Kinase Inhibitor in Chronic Myeloid Leukemia

      Not yet recruiting
      • Tyrosine Kinase Inhibitor
      • +2 more
        • Taipei, Taiwan
          National Taiwan University Hospital
        Feb 17, 2022

        Chronic Myeloid Leukemia Trial in Spain (Ponatinib)

        Recruiting
        • Chronic Myeloid Leukemia
        • Ponatinib
        • Badalona, Barcelona, Spain
        • +8 more
        Aug 1, 2019

        B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Trial in Israel, United States (Blinatumomab,

        Recruiting
        • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
        • Blinatumomab
        • +10 more
        • Anchorage, Alaska
        • +152 more
        Aug 11, 2022

        Healthy (For Part A), Chronic Myeloid Leukemia (for Part B and C) Trial in Worldwide (Vodobatinib (K0706) capsules)

        Recruiting
        • Healthy (For Part A)
        • Chronic Myeloid Leukemia (for Part B and C)
        • Vodobatinib (K0706) capsules
        • Downey, California
        • +69 more
        Dec 7, 2022